BANK OF AMERICA CORP /DE/ - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 91 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 6.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$24,000
-29.4%
24,510
-12.6%
0.00%
Q1 2022$34,000
-75.5%
28,057
-34.0%
0.00%
Q4 2021$139,0000.0%42,497
+36.5%
0.00%
Q3 2021$139,000
-22.8%
31,144
-5.7%
0.00%
Q2 2021$180,000
-41.7%
33,014
-20.0%
0.00%
Q1 2021$309,000
+102.0%
41,286
+192.6%
0.00%
Q4 2020$153,000
-68.8%
14,108
-74.6%
0.00%
Q3 2020$491,000
+143.1%
55,488
+193.7%
0.00%
Q2 2020$202,000
+57.8%
18,890
-12.1%
0.00%
Q1 2020$128,000
+23.1%
21,500
+42.6%
0.00%
Q4 2019$104,000
-26.8%
15,081
+10.0%
0.00%
Q3 2019$142,000
+89.3%
13,715
+70.7%
0.00%
Q2 2019$75,000
+8.7%
8,034
+6.7%
0.00%
Q1 2019$69,000
-29.6%
7,527
-56.7%
0.00%
Q4 2018$98,000
+44.1%
17,400
+205.9%
0.00%
Q3 2018$68,000
+78.9%
5,689
+54.1%
0.00%
Q2 2018$38,000
+137.5%
3,691
+206.1%
0.00%
Q1 2018$16,000
+14.3%
1,206
-18.8%
0.00%
Q4 2017$14,000
+27.3%
1,485
+105.7%
0.00%
Q3 2017$11,000
+120.0%
722
+131.4%
0.00%
Q2 2017$5,000
-61.5%
312
-62.1%
0.00%
Q1 2017$13,000
+62.5%
824
+29.0%
0.00%
Q4 2016$8,0006390.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 4,806,656$58,449,00019.02%
Casdin Capital, LLC 182,141$2,215,0001.83%
Aisling Capital LLC 508,565$6,184,0001.44%
Redmile Group, LLC 948,440$11,533,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,812,778$22,043,0000.91%
EcoR1 Capital, LLC 63,596$773,0000.25%
Eventide Asset Management 150,000$1,824,0000.12%
AWM Investment Company, Inc. 47,550$578,0000.11%
Weiss Multi-Strategy Advisers LLC 49,000$596,0000.03%
Baker Brothers Advisors 204,465$2,486,0000.02%
View complete list of SYROS PHARMACEUTICALS INC shareholders